Hookipa Pharma Inc. Conducted Special Stockholder Meeting to Vote on Key Proposals
Hookipa Pharma Inc. held a special stockholder meeting on July 29, 2025, where stockholders approved the sale of certain assets to Gilead Sciences, Inc. and the company's liquidation and dissolution as per the Plan of Dissolution. The proposal to adjourn the meeting for additional proxy solicitation was also approved.
Hookipa Pharma Inc. held a special meeting of stockholders on July 29, 2025. During the meeting, stockholders approved the sale of certain assets of the company pursuant to an Asset Purchase Agreement with Gilead Sciences, Inc. Additionally, the liquidation and dissolution of the company, as outlined in the Plan of Dissolution, received approval. The proposal to adjourn the meeting, if necessary to solicit additional proxies, was also approved. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hookipa Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-071716), on July 29, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
